On June 2nd 2020, Mylan updated its Epipen website to say:
Having previously experienced manufacturing challenges, supply has stabilised in the UK and there is good availability of both EpiPen Jr 0.15mg and EpiPen 0.3mg AAIs. The prescription validation process previously applied is no longer in place and stock can be ordered as normal.
This means that pharmacies are now able to place orders through Alliance Healthcare and hold stock for both Epipen Junior 0.15mg and Epipen 0.3mg devices to enable them to fulfil patient prescriptions without any delay.
For more information visit Epipen.co.uk